Skip to main content

Fresenius Medical Care Value Stock - Dividend - Research Selection

Fresenius Medical Care AG & Co. KGaA

ISIN: DE0005785802 , WKN: 578580

Market price date: 22.05.2020
Market price: 75,16 EUR

Fresenius Medical Care AG & Co. KGaA Fundamental data and company key figures of the share

Annual reports in EUR
Key figures 26-02-2020
Cash flow
Net operating cash flow 2.566.950.000
Capital Expenditures -1.124.790.000
Free cash flow 1.442.160.000
Balance sheet
Total Equity
Liabilities & Shareholders equity 32.935.000.000
Income statement
Net income
Eps (diluted) 3,960
Diluted shares outstanding 298.000.000
Net sales/revenue 17.477.000.000

Fundamental ratios calculated on: 22-05-2020

Key figures 22-05-2020
Cash flow
P/C 8,73
P/FC 15,53
Balance sheet
Income statement
Div. Yield1,60%

Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.

Market Capitalization24.422.287.360,00 USD
SectorsHealth service
Raw Data SourceIFRS in Millionen EUR
Stock Split2007-06-18,3.0000/1.0000

Description of the company

Fresenius Medical Care AG & Co. KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient\'s residence; and dialysis services under contract to hospitals in the U.S. for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and water treatment systems for the treatment of ESRD; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, hospitalist and intensivist, medical cost management, ambulatory surgery center, health plan, urgent care, physician nephrology and cardiology, and ambulant treatment services. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; and offers non-dialysis products, including acute cardiopulmonary and apheresis products. The company sells its products to clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of December 31, 2017, it operated 3,752 outpatient dialysis clinics in approximately 50 countries. The company has operations in Germany, the United States, and internationally. Fresenius Medical Care AG & Co. KGaA was founded in 1996 and is headquartered in Bad Homburg, Germany.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources::,,